On three-dimensional holographic vector of atomic interaction field analysis for influenza neuraminidase inhibitors

Chemical Biology and Drug Design

Volumn 73, Issue 2, 2009, Pages 236-243

  Li, Zhiliang S ^a,b   Sun, Jiaying Y ^a,b   Liang, Guizhao Z ^a,b   Lu, Fenglin L ^a,b   Zhu, Wanping P ^a   Zhang, Mengjun J ^a,b   Zhang, Yonghong ^a,b   Yang, Shanbin B ^a,b   Shu, Mao ^a,b   Chen, Guohua H ^a,b   Lu, Tingting T ^a,b  

^a CHONGQING UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

3D quantitative structure activity relationship (3D QSAR); Influenza neuraminidase inhibitors; Three dimensional holographic vector of atomic interaction field analysis (HoVAIFA)

Indexed keywords

SIALIDASE; SIALIDASE INHIBITOR;

ARTICLE; DRUG STRUCTURE; HOLOGRAPHY; INFLUENZA; INFLUENZA VIRUS; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; THREE DIMENSIONAL HOLOGRAPHIC VECTOR OF ATOMIC INTERACTION FIELD ANALYSIS;

ALGORITHMS; ANTIVIRAL AGENTS; ENZYME INHIBITORS; HOLOGRAPHY; INFLUENZA A VIRUS; MODELS, MOLECULAR; NEURAMINIDASE; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; REGRESSION ANALYSIS;

ORTHOMYXOVIRIDAE; RNA VIRUSES;

EID: 58849088105     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2008.00767.x     Document Type: Article

References (30)

1. Service R.F. (1997) Researchers seek new weapon against the flu. Science 275 : 756 757.
2. Von Itzstein M., Wu W.Y., Kok G.B., Pegg M.S., Dyason J.C., Jin B., Phan T.V. et al. (1993) Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363 : 418 423.
3. Kim C.U., Bischofberger N., Williams M.A., Lew W., Merson J., Sweet C. (1997) Efficacy of GS 4104 in ferrets infected with influenza A virus. J Antiviral Res Soc A74 34.
4. Dunn C.J., Goa K.L. (1999) Zanamivir; a reviewof its use in influenza. Drugs 58 : 761.
5. Smith P.W., Starkey I.D., Howes P.D., Sollis S.L., Keeling S.P., Cherry P.C., von Itzstein M., Wu W.Y., Jin B. (1996) Synthesis and influenza virus sialidase inhibitory activity of analogues of 4-guan idino-Neu5Ac2en (GG167) with modified 5-substituents. J Med Chem 31 : 143 150.
6. Fromtling R.A. (2000) Zanamivir. Drugs Fut 25 : 430 433.
7. Singh S., Jedrzejas M.J., Air G.M., Luo M. (1995) Structure-based inhibitors of influenza virus sialidase A benzoic acid leads withnovel interaction. J Med Chem 38 : 3217 3225.
8. Chand P., Babu Y.S., Bantia S., Chu N., Cole L.B., Kotian P.L. (1997) Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design. J Med Chem 40 : 4030 4052.
9. Howes P.D., Cleasby A., Evans D.N., Feilden H., Smith P.W., Sollis S.L., Taylor N., Wonacott A.J. (1999) 4-Acetylamino-3-(imidazol-1-yl)-benzoic acids as novel inhibitors of influenza sialidase. J Med Chem 34 : 225 234.
10. Williams M.A., Lew W., Mendel D.B., Tai C.Y., Escarpe P.A., Laver W.G., Stevens R.C., Kim C.U. (1997) Structure-activity relationships of carbocyclic influenza neuraminidase inhibitors. J Am Chem Soc 7 : 1837 1842.
11. Mendel D.B., Tai C.Y., Escarpe P.A., Li W.X., Kim C.U., Williams M.A., Lew W., Zhang L., Bischofberger N., Huffman J.H. (1998) GS 4071 is a potent and selective inhibitor of the growth and neuraminidase activity of influenza A and B viruses. J Med Chem 41 : 2451 2460.
12. Li W.X., Escarpe P.A., Eisenberg E.J., Cundy K.C., Sweet C., Jakeman K.J., Merson J., Lew W., Williams M., Zhang L.J., Kim C.U., Bischofberger N., Chen M.S., Mendel D.B. (1998) Identification of GS4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS4071. Antimicrob Agents Chemother 42 : 647 653.
13. Ives J.A.L., Carr J.A., Mendel D.B., Tai C.Y., Lambkin R., Kelly L., Oxford J.S., Hayden F.G., Roberts N.A. (2002) The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. JAMA 7 : 307 317.
14. Liu Z.Y., Wu Y.G., Li Z.R. (2002) Screening and synthesis of influenza neuraminidase inhibitors. Chin J Antibiot 27 : 529 531.
15. Sorbera L.A. (2000) RWJ-270201. Drugs Fut 25 : 249 251.
16. Verma R.P., Hansch C. (2006) A QSAR study on influenza neuraminidase inhibitors. Bioorg Med Chem 14 : 982 996.
17. Liu S.S., Cai S.C., Cao C.Z., Li Z.S. (2000) Molecular electronegative distance vector (MEDV) related to 15 properties of alkanes. J Chem Inf Comput Sci 40 : 1337 1348.
18. Zhao C., Maring C., Sun M., Stewart K., Stoll V., Xu Y., Gu Y. et al. (2001) Design, synthesis and activity of substituted pyrrolidine influenza neuraminidase inhibitors. J Med Chem 44 : 1192 1201.
19. Levitt M. (1983) Protein folding by restrained energy minimization and molecular dynamics. J Mol Biol 170 : 723 764.
20. Levitt M., Perutz M.F. (1988) Aromatic rings act as hydrogen bond acceptors. J Mol Biol 201 : 751 754.
21. Kellogg G.E., Burnett J.C., Abraham D.J. (2001) Very empirical treatment of solvation and entropy; a force field derived from log Po/w. J Comput Aided Mol Des 15 : 381 393.
22. Kellogg G.E., Semus S.F., Abraham D.J. (1991) HINT-a new method of empirical hydrophobic field calculation for CoMFA. J Comput Aided Mol Des 5 : 545 552.
23. Hahn M. (1995) Receptor surface models. 1. Definition and construction. Med Chem 38 : 2080 2090.
24. Abraham D.J., Kellogg G.E., Holt J.M., Ackers G.K. (1997) Hydropathic analysis of the non-covalent interactions between molecular subunits of structurally characterized hemoglobins. Mol Biol 272 : 613 632.
25. Gunnarsson G.T., Umesh R.D. (2004) Hydropathic interaction analyses of small organic activators binding to antithrombin. Bioorg Med Chem 12 : 633 640.
26. Kellogg G.E., Joshi G.S., Abraham D.J. (1992) New tools for modeling and understanding hydrophobicity and hydrophobic interactions. Med Chem Res 1 : 444 453.
27. Kellogg G.E., Abraham D.J. (1992) Complementary hydrophobicity map predictions of drug structure from a known receptor/receptor structure from known drugs. Mol Graph 10 : 212 217.
28. Hasel W., Hendrikson T.F., Still W.C. (1988) A rapid approximation to the solvent accessible surface areas of atoms. Tetrahedron Comp Method 1 : 103 116.
29. Pei J., Wang Q., Zhou J., Lai L. (2004) Estimating protein-ligand binding free energy; atomic solvation parameters for partition coefficient and solvation free energy calculation. Proteins 57 : 651 664.
30. Golbraikh A., Tropsha A. (2002) Beware of Q2! J Mol Graph Model 20 : 269 276.